UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 17.

Havranek, M M; Vonmoos, Matthias; Müller, C P; Büetiger, J R; Tasiudi, Eve; Hulka, Lea M; Preller, Katrin H; Mössner, R; Grünblatt, Edna; Seifritz, Erich; Quednow, B B (2015). Serotonin transporter and tryptophan hydroxylase gene variations mediate working memory deficits of cocaine users. Neuropsychopharmacology, 40:2929-2937.

Easton, A C; Lourdusamy, A; Havranek, M; Mizuno, K; Solati, J; Golub, Y; Clarke, T-K; Vallada, H; Laranjeira, R; Desrivières, S; Moll, G H; Mössner, R; Kornhuber, J; Schumann, G; Giese, K P; Fernandes, C; Quednow, B B; Müller, C P (2014). αCaMKII controls the establishment of cocaine's reinforcing effects in mice and humans. Translational Psychiatry, 4(e457):online.

Petrovsky, N; Ettinger, U; Kessler, H; Mössner, R; Wolfsgruber, S; Dahmen, N; Maier, W; Wagner, M; Quednow, B B (2013). The effect of nicotine on sensorimotor gating is modulated by a CHRNA3 polymorphism. Psychopharmacology, 229(1):31-40.

Petrowsky, N; Ettinger, U; Quednow, B B; Landsberg, M W; Drees, J; Lennertz, L; Frommann, I; Heilmann, K; Sträter, B; Kessler, H; Dahmen, N; Mössner, R; Maier, W; Wagner, M (2013). Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls. International Journal of Neuropsychopharmacology, 16(07):1473-1481.

Schumacher, Anna; Becker, Tim; Rujescu, D; Quednow, B B; Lennertz, L; Wagner, M; Benninghoff, J; Rietschel, M; Häfner, H; Franke, P; Wölwer, W; Gaebel, W; Maier, W; Mössner, R (2012). Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics. Journal of Psychiatric Research, 46(8):1073-1080.

Petrovsky, N; Ettinger, U; Quednow, B B; Walter, H; Schnell, K; Kessler, H; Mössner, R; Maier, W; Wagner, M (2012). Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy. Psychopharmacology, 221(1):27-38.

Lennertz, L; Quednow, B B; Schuhmacher, D; Petrovsky, N; Frommann, I; Schulze-Rauschenbach, S; Landsberg, M W; Steinbrecher, A; Höfels, S; Pukrop, R; Klosterkötter, J; Franke, P E; Wölwer, W; Gaebel, W; Häfner, H; Maier, W; Wagner, M; Mössner, R (2012). The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response. International Journal of Neuropsychopharmacology, 15(09):1205-1215.

Mössner, R; Schumacher, A; Wagner, M; Lennertz, L; Steinbrecher, A; Quednow, B B; Rujescu, D; Rietschel, M; Maier, W (2012). The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms. European Archives of Psychiatry and Clinical Neuroscience, 262(3):193-197.

Lennertz, L; Quednow, B B; Benninghoff, J; Wagner, M; Maier, W; Mössner, R (2011). Impact of TCF4 on the genetics of schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 261(Suppl 2):161-165.

Quednow, B B; Ettinger, U; Mössner, R; Rujescu, D; Giegling, I; Collier, D A; Schmechtig, A; Kühn, K U; Möller, H J; Maier, W; Wagner, M; Kumari, V (2011). The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. Journal of Neuroscience, 31(18):6684-6691.

Mössner, R; Schumacher, A; Wagner, M; Quednow, B B; Frommann, I; Kühn, K U; Schwab, S G; Rietschel, M; Falkai, P; Wölwer, W; Ruhrmann, S; Bechdolf, A; Gaebel, W; Klosterkötter, J; Maier, W (2010). DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis. European Archives of Psychiatry and Clinical Neuroscience, 260(3):209-215.

Quednow, B B; Wagner, M; Mössner, R; Maier, W; Kühn, K U (2010). Sensorimotor gating of schizophrenia patients depends on catechol O-methyltransferase Val158Met polymorphism. Schizophrenia Bulletin, 36(2):341-346.

Petrovsky, N; Quednow, B B; Ettinger, U; Schmechtig, A; Mössner, R; Collier, D A; Kühn, K U; Maier, W; Wagner, M; Kumari, V (2010). Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. Neuropsychopharmacology, 35(7):1429-1439.

Schumacher, A; Mössner, R; Quednow, B B; Kühn, K U; Wagner, M; Cvetanovska, G; Rujescu, D; Zill, P; Möller, H J; Rietschel, M; Franke, P; Wölwer, W; Gaebel, W; Maier, W (2009). Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia. Pharmacogenetics and Genomics, 19(11):843-851.

Mössner, R; Schumacher, A; Kühn, K U; Cvetanovska, G; Rujescu, D; Zill, P; Quednow, B B; Rietschel, M; Wölwer, W; Gaebel, W; Wagner, M; Maier, W (2009). Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia. Pharmacogenetics and Genomics, 19(1):91-94.

Maier, W; Mössner, R; Quednow, B B; Wagner, M; Hurlemann, R (2008). From genes to psychoses and back: the role of the 5HT2alpha-receptor and prepulse inhibition in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 258(Supp. 5):40-43.

Quednow, B B; Kühn, K U; Mössner, R; Schwab, S G; Schuhmacher, A; Maier, W; Wagner, M (2008). Sensorimotor gating of schizophrenia patients is influenced by 5-HT2A receptor polymorphisms. Biological Psychiatry, 64(5):434-437.

This list was generated on Wed Jul 26 05:03:56 2017 CEST.